Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

Jun 09 • 04:00PM ET

7.85

+0.14 1.82 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN INCY RYTM KYMR NUVL VKTX AXSM NBIX

| Held by: VTI VXF IBB SURI SCHA DWAS IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.28	Insider Own	38.20%	Shs Outstand	60.53M	Perf Week	-0.63%
Market Cap	477.24M	Forward P/E	-	EPS next Y	-2.94	Insider Trans	1.06%	Shs Float	37.57M	Perf Month	-16.04%
Enterprise Value	274.55M	PEG	-	EPS next Q	-0.68	Inst Own	42.34%	Short Float	15.28%	Perf Quarter	-14.95%
Income	-156.40M	P/S	-	EPS this Y	21.28%	Inst Trans	0.85%	Short Ratio	6.15	Perf Half Y	0.64%
Sales	0.00M	P/B	2.43	EPS next Y	-2.66%	ROA	-60.42%	Short Interest	5.74M	Perf YTD	-16.49%
Book/sh	3.23	P/C	2.02	EPS next 5Y	13.10%	ROE	-74.55%	52W High	13.67 -42.57%	Perf Year	127.54%
Cash/sh	3.89	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-68.79%	52W Low	2.52 211.51%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.92% 7.21%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	2.58%	Oper. Margin	-	ATR (14)	0.57	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.15	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.18	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.15	EPS Q/Q	36.35%	SMA20	-9.72%	Beta	1.94	Target Price	30.40
Payout	-	Debt/Eq	0.17	Sales Q/Q	-	SMA50	-13.00%	Rel Volume	0.78	Prev Close	7.71
Employees	130	LT Debt/Eq	0.16	Earnings	May 12 AMC	SMA200	1.79%	Avg Volume	932.44K	Price	7.85
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.20% -	Trades		Volume	729,379	Change	1.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)